The Canadian COVID‑19 Funded Research Database

Lady Davis Institute for Medical Research

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 121 through 130 of 150 results (Download Results)

Show results per page

COVID-19 Variant Supplement – Preventing SARS-CoV-2 infection by targeting human type II transmembrane serine protease activity

Leduc, Richard | Université de Sherbrooke | Operating Grant | $50,000

CIHR Quebec 2021

A cell-based assay to measure immune competence in SARS-CoV-2 infection and vaccination

De Serres, Sacha | Université Laval | Operating Grant | $246,164

CIHR Quebec 2021

Prevention of the immunopathology induced by SARS-CoV-2

Estaquier, Jérôme | Université Laval | Operating Grant | $499,800

CIHR Quebec 2021

COVID-19 Variant Supplement – Understand the high pathogenicity and zoonotic transmission of the COVID‑19 virus: evasion of host innate immune responses

Liang, Chen | Lady Davis Institute for Medical Research | Operating Grant | $50,000

CIHR Quebec 2021

COVID-19 Variant Supplement – Genre et intervention en dépendance en contexte de pandémie auprès de personnes en situation de précarité sociale

Bertrand, Karine | Université de Sherbrooke | Operating Grant | $50,000

CIHR Quebec 2021

Developing a novel vaccine against COVID-19

Divangahi, Maziar | McGill University | Project Grant | $569,925

CIHR Quebec 2021

Impact of Frailty and Sarcopenia on Post-COVID Recovery

Afilalo, Jonathan | CIUSSS de Centre-Ouest-de-l'Ile-de-Montréal-Jewish General | Operating Grant | $470,179

CIHR Quebec 2021

COVID-19 Variant Supplement – Understanding the pathogenesis of COVID-19

Flamand, Louis | CHU de Québec | Operating Grant | $50,000

CIHR Quebec 2021

Pathogenesis and immune escape potential of SARS-CoV-2 variants of concern.

Flamand, Louis | CHU de Québec | Operating Grant | $252,900

CIHR Quebec 2021

COVID-19 Variant Network – Innovative therapeutic approaches for the 2019-novel coronavirus

Boivin, Guy | CHU de Québec | Operating Grant | $100,000

CIHR Quebec 2021

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

COVID-19 Variant Supplement – Preventing SARS-CoV-2 infection by targeting human type II transmembrane serine protease activity

A cell-based assay to measure immune competence in SARS-CoV-2 infection and vaccination

Prevention of the immunopathology induced by SARS-CoV-2

COVID-19 Variant Supplement – Understand the high pathogenicity and zoonotic transmission of the COVID‑19 virus: evasion of host innate immune responses

COVID-19 Variant Supplement – Genre et intervention en dépendance en contexte de pandémie auprès de personnes en situation de précarité sociale

Developing a novel vaccine against COVID-19

Impact of Frailty and Sarcopenia on Post-COVID Recovery

COVID-19 Variant Supplement – Understanding the pathogenesis of COVID-19

Pathogenesis and immune escape potential of SARS-CoV-2 variants of concern.

COVID-19 Variant Network – Innovative therapeutic approaches for the 2019-novel coronavirus